SCHEMBL1738423

SCHEMBL1738423

COc1ccc(-c2ncccc2[N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 1/20 0.56
HPGD P15428 1/20 0.56
CLK4 Q9HAZ1 1/20 0.53
TRPV1 Q8NER1 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
KMT2A Q03164 2/20 0.50
RAB9A P51151 2/20 0.50
HTR7 P34969 1/20 0.48
KCNA5 P22460 1/20 0.47
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
MEN1 O00255 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 2/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
NFKB2 Q00653 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31451585 1.00 NPC1 (0.56) NPC1ALDH1A1KDM4EHPGDCLK4
SCHEMBL28022002 0.86 TRPV1 (0.47) NPC1ALDH1A1KDM4EHPGDTRPV1
SCHEMBL27866903 0.84 DYRK1A (0.56) NPC1ALDH1A1CLK4SMN1; SMN2KMT2A
SCHEMBL1736457 0.83 PAX8 (0.57) ALDH1A1TRPV1SMN1; SMN2KMT2ARAB9A
SCHEMBL5918022 0.81 CTSB (0.51) NPC1ALDH1A1KDM4EHPGDTRPV1
SCHEMBL444703 0.80 ALDH1A1 (0.53) NPC1ALDH1A1TRPV1KMT2ARAB9A
SCHEMBL1738384 0.80 MAPT (0.52) ALDH1A1KDM4ETRPV1KMT2ARAB9A
SCHEMBL1736168 0.80 MEN1 (0.57) ALDH1A1KDM4ETRPV1SMN1; SMN2KMT2A
SCHEMBL27930436 0.80 TRPV1 (0.51) ALDH1A1TRPV1KMT2ARAB9AMAPT
SCHEMBL28567279 0.79 PDE10A (0.50) ALDH1A1TRPV1SMN1; SMN2KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250367173-A1 ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME LIGACHEM BIOSCIENCES INC (KR) 2025-12-04 US disclosed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
EP-1784404-A4 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2009-09-09 EP disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed
EP-1784404-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2007-05-16 EP disclosed
WO-2006025716-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2006-03-09 WO disclosed
US-20060041144-A1 Phenylpyridine compound and fungicidal compostion containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-02-23 US disclosed
EP-1541557-A1 PHENYLPYRIDINE COMPOUND AND BACTERICIDAL COMPOSITION CONTAINING THE SAME Sumitomo Chemical Company, Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250367173-A1 ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME ENPP1, ENPP3, SMPD1 NPC1 1774/4885ALDH1A1 1210/4885KDM4E 2886/4885
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H NPC1 2915/4885ALDH1A1 2163/4885KDM4E 1107/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H NPC1 2915/4885ALDH1A1 2163/4885KDM4E 1107/4885
US-20060041144-A1 Phenylpyridine compound and fungicidal compostion containing the same CBR3, CYP1A1, PAH NPC1 4092/4885ALDH1A1 2020/4885KDM4E 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.